Literature DB >> 27720266

Burn leads to long-term elevated admissions to hospital for gastrointestinal disease in a West Australian population based study.

Andrew W Stevenson1, Sean M Randall2, James H Boyd3, Fiona M Wood4, Mark W Fear5, Janine M Duke6.   

Abstract

BACKGROUND: While the most obvious impact of burn is on the skin, systemic responses also occur after burn, including intestinal inflammation. The objective of this study was to assess if burns are associated with increased long-term admissions for gastrointestinal diseases.
METHODS: A population-based longitudinal study using linked hospital morbidity and death data from Western Australia was undertaken of adults aged at least 15 years when hospitalized for a first burn (n=20,561) in 1980-2012. A frequency matched non-injury comparison cohort was randomly selected from Western Australia's birth registrations and electoral roll (n=80,960). Crude admission rates and summed days in hospital for digestive diseases were calculated. Negative binomial and Cox proportional hazards regression modeling were used to generate incidence rate ratios (IRR) and hazard ratios (HR), respectively.
RESULTS: After adjustment for demographic factors and pre-existing health status, the burn cohort had 1.54 times (95% confidence interval (CI): 1.47-1.62) as many admissions and almost three times the number of days in hospital with a digestive system diagnosis (IRR, 95% CI: 2.90, 2.60-3.25) than the uninjured cohort. Significantly elevated adjusted post-burn incident rates were identified, with the risk decreasing with increasing time: in the first month (HR, 95% CI: 3.02, 1.89-4.82), from one month to five years (HR, 95% CI: 1.42, 1.31-1.54), and from five to twenty years after burn (HR, 95% CI: 1.13, 1.06-1.20).
CONCLUSIONS: Findings of increased hospital admission rates and prolonged length of hospital stay for gastrointestinal diseases in the burn cohort provide evidence to support that burns have effects that persist long after the initial injury.
Copyright © 2016 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Adults; Burns; Gastrointestinal disease; Long-term health; Population-based cohort

Mesh:

Year:  2016        PMID: 27720266     DOI: 10.1016/j.burns.2016.09.009

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  5 in total

1.  Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells.

Authors:  Lucy W Barrett; Vanessa S Fear; Bree Foley; Katherine Audsley; Samantha Barnes; Hannah Newnes; Alison McDonnell; Fiona M Wood; Mark W Fear; Jason Waithman
Journal:  Burns Trauma       Date:  2022-04-29

Review 2.  Understanding acute burn injury as a chronic disease.

Authors:  Lucy W Barrett; Vanessa S Fear; Jason C Waithman; Fiona M Wood; Mark W Fear
Journal:  Burns Trauma       Date:  2019-09-16

3.  Improved and standardized method for assessing years lived with disability after burns and its application to estimate the non-fatal burden of disease of burn injuries in Australia, New Zealand and the Netherlands.

Authors:  Inge Spronk; Dale W Edgar; Margriet E van Baar; Fiona M Wood; Nancy E E Van Loey; Esther Middelkoop; Babette Renneberg; Caisa Öster; Lotti Orwelius; Asgjerd L Moi; Marianne Nieuwenhuis; Cornelis H van der Vlies; Suzanne Polinder; Juanita A Haagsma
Journal:  BMC Public Health       Date:  2020-01-29       Impact factor: 3.295

4.  Systemic long-term metabolic effects of acute non-severe paediatric burn injury.

Authors:  Sofina Begum; Blair Z Johnson; Aude-Claire Morillon; Rongchang Yang; Sze How Bong; Luke Whiley; Nicola Gray; Vanessa S Fear; Leila Cuttle; Andrew J A Holland; Jeremy K Nicholson; Fiona M Wood; Mark W Fear; Elaine Holmes
Journal:  Sci Rep       Date:  2022-07-29       Impact factor: 4.996

5.  Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine Response.

Authors:  Blair Z Johnson; Sonia McAlister; Helen M McGuire; Vetrichevvel Palanivelu; Andrew Stevenson; Peter Richmond; Debra J Palmer; Jessica Metcalfe; Susan L Prescott; Fiona M Wood; Barbara Fazekas de St Groth; Matthew D Linden; Mark W Fear; Vanessa S Fear
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.